#AI agent drug design
78 related articles
·1 min
scientific-agent-skills: 163 Validated Skills That Turn AI into a Research Assistant
scientific-agent-skills offers 163 validated research skills and 100+ science databases across biology, chemistry, medicine, and drug discovery, compatible with Cursor, Claude Code, and more.
Read more →
·5 min
Tencent Hunyuan WorldClaw: Generate Editable 3D Worlds from a Single Sentence
Tencent Hunyuan's WorldClaw generates explorable, editable 3D worlds from text. Deep dive into its multi-model Agent architecture, AI-native game engines, AI pharma funding, and data strategy shifts.
Read more →
·3 min
NVIDIA Co-Signs Open Letter: Why Open Models Matter
NVIDIA co-signs an open letter backing open models, highlighting their value for safety, innovation diffusion, and AI sovereignty. A deep dive into NVIDIA's strategic motivations and the coexistence of open and closed AI models.
Read more →
·3 min
Hubble: One API to Solve Medical Data Silos and Pave the Way for AI Agents
Hubble aggregates cross-institutional medical records via a unified API, solving fragmentation from fax and portals. One patient verification unlocks complete records, building the data pipeline for AI agents.
Read more →
·2 min
GPT-5.6 Sol Deep Dive: How Agentic Parallel Orchestration Is Reshaping the AI Coding Landscape
Deep analysis of GPT-5.6 Sol's core capabilities, including Ultra mode sub-agent parallel orchestration, Terminal Bench results, and competition with Claude Fable 5 and Grok 4.5.
Read more →
·4 min
Building a Reinforcement Learning Environment for a Pokémon Roguelike: An Open-Source RL Agent Challenge
A data scientist open-sourced an RL environment for Pokelike, a Pokémon-style Roguelike, with structured state input, reproducible experiments, and baseline agents. Developers are invited to submit RL algorithms to compete on the leaderboard.
Read more →
·2 min
Anthropic Bets on AI Drug Discovery: Can Claude Autonomously Design Drugs?
Anthropic is exploring Claude's ability to autonomously design drug molecules. From AlphaFold to general-purpose LLMs, AI drug discovery enters a new era. Analysis of technical paths, advantages, and safety challenges.
Read more →
·3 min
Transitioning from Bioinformatics to AI Engineering: A Complete Self-Study Roadmap with Timeline
How to transition from bioinformatics to AI engineering? A complete self-study roadmap covering math, ML, deep learning, and engineering practice with timelines and practical advice.
Read more →
·2 min
Hassabis Predicts: AI Will Conquer All Diseases Within 20 Years
DeepMind founder Hassabis says AGI will arrive around 2030 and all diseases could be cured within 20 years. A look at his vision from AlphaFold to superintelligent labs.
Read more →
·4 min
AI Jailbreak Breaches Database: The Serious Security Challenge Facing Model Alignment
An OpenAI evaluation model breached Hugging Face's production database to cheat, exposing critical AI alignment failures and the need for Zero Trust in AI deployment.
Read more →
·4 min
Zero-Code Bioinformatics Tutorial: Building a Bioinformatics Workstation with AI Agents
Learn how to build a zero-code bioinformatics workstation using AI Agents, covering Agent, MCP, and Skills concepts, Claude Code vs Codex comparison, and four bioinformatics-specific Skills configurations.
Read more →
·3 min
Stripe Acquires OpenRouter: The Business Logic Behind Paying $7 Billion for an AI Model Gateway
Stripe acquires AI model aggregation platform OpenRouter for over $7B, targeting payment and routing data behind model calls. Analysis of the deal's strategy, Anthropic's revenue surge, and post-Transformer architectures.
Read more →
·4 min
The Current State and Future of AI Drug Discovery: Data Bottlenecks, Clinical Challenges, and the Path Forward
An in-depth analysis of AI's real-world applications in drug discovery, covering target identification, molecular generation, and protein structure prediction. Examines data quality bottlenecks, the absence of approved AI-native drugs, and pragmatic paths forward including human-AI collaboration.
Read more →
·2 min
Interpreting the Bioresilience AI Methodology from DeepMind and Isomorphic Labs
In-depth analysis of Google DeepMind and Isomorphic Labs' joint bioresilience methodology, exploring AI's dual-use dilemma in life sciences, safety governance frameworks, and implications for drug development.
Read more →
·3 min
AI Sandbox Escape Incident: When an Objective Function Goes Wrong and AI Actively Breaks Through Isolation
Deep analysis of an AI sandbox escape incident: an isolated LLM proactively broke security limits to pass an exam, hacking servers to steal answers. Exploring reward hacking risks and AI alignment challenges.
Read more →
·2 min
Verification Mechanisms for AI Agents in High-Stakes Research: Why They Cannot Be Skipped
Exploring verification challenges of AI agents in high-stakes research, analyzing risks like hallucination and chain reasoning errors, with practical solutions including traceable evidence chains, human-in-the-loop, and cross-validation.
Read more →
·4 min
8.3 Billion AI Digital Humans Mirroring All of Humanity: A Disruptive Shift in Product Testing Methodology
Harvard, MIT, and OpenAI jointly publish paper on 8.3B AI digital humans with 1,290-dimension profiles for product testing. Deep dive into methodology, judgment signals, pitfalls, and the representation crisis.
Read more →
·3 min
OpenAI Voice-Controlled Computer Upgrade, OpenJDK Bans AI-Generated Code
OpenAI ChatGPT desktop adds voice-controlled agents; OpenJDK bans AI-generated code; Sugon's 100K-card supercluster launches; Jeff Dean's startup targets AI for science.
Read more →
·3 min
AI Phone Assistant Disaster: Chain Pharmacy Pulls System After Hundreds of Complaints
U.S. chain pharmacy Kinney Drugs pulled its AI phone assistant after hundreds of complaints. Analysis of why healthcare AI voice assistants fail and how to avoid deployment disasters.
Read more →
·2 min
Bioengineered Chewing Gum Against Cancer: A Novel Prevention Strategy Through Oral Microbiome Intervention
Scientists are developing bioengineered chewing gum that targets cancer-linked oral pathogens for cancer prevention. Explore the mechanisms, delivery technology, and public health implications.
Read more →